Current NDC auxiliary source row compounder:1097

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-2590
Product Ndc: 72934-2590
Product Ndc Digits: 729342590
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Admirazol
Proprietary Name Suffix: HP
Nonproprietary Name: 011557 DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%
Dosage Form Name: CREAM
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: SPIRONOLACTONE; DAPSONE; NIACINAMIDE
Active Ingredients Info: 5 g/100 g; 8.5 g/100 g; 2 g/100 g
History Active Ingredients Raw: SPIRONOLACTONE; DAPSONE; NIACINAMIDE
History Active Ingredients Info Raw: 5 g/100 g; 8.5 g/100 g; 2 g/100 g
History Dosage Raw: CREAM
Dea Schedule: [empty]
Package Ndc Raw: 72934-2590-2
Package Ndc: 72934-2590-2
Package Ndc Digits: 7293425902
Package Ndc11: 72934259002
Package Description: 30 g in 1 BOTTLE, PUMP (72934-2590-2)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:1097
Source Row Number: 1097
Source Row Hash: 20ef5f45ac8a3d9afe16ca2289fe57c39b9f0a8092b3433dd3a529b6c1a82f8c
Import Run Id: 20261020T105720Z
Loaded At: 2026-10-20 11:03:50

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-2590",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "SPIRONOLACTONE; DAPSONE; NIACINAMIDE",
    "DOSAGEFORMNAME": "CREAM",
    "NDCPACKAGECODE": "72934-2590-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Admirazol",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "011557 DAPSONE 8.5% / NIACINAMIDE 2% / SPIRONOLACTONE 5%",
    "PACKAGEDESCRIPTION": "30 g in 1 BOTTLE, PUMP (72934-2590-2) ",
    "ACTIVEINGREDIENTSINFO": "5 g/100 g; 8.5 g/100 g; 2 g/100 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": "HP"
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:1097
Source Row Number: 1097
Status Scope: package
Lookup Ndc: 72934-2590-2
Lookup Ndc Digits: 7293425902
Product Ndc: 72934-2590
Product Ndc Digits: 729342590
Package Ndc: 72934-2590-2
Package Ndc Digits: 7293425902
Package Ndc11: 72934259002
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 20ef5f45ac8a3d9afe16ca2289fe57c39b9f0a8092b3433dd3a529b6c1a82f8c
Import Run Id: 20261020T105720Z
Loaded At: 2026-10-20 11:03:50